tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sutro Biopharma enters research collaboration with FDA for ADC standards
PremiumThe FlySutro Biopharma enters research collaboration with FDA for ADC standards
2M ago
Sutro Biopharma Faces NASDAQ Non-Compliance Notice
Premium
Company Announcements
Sutro Biopharma Faces NASDAQ Non-Compliance Notice
3M ago
Sutro, Sarepta, Incyte, Signet, Wix: Trending by Analysts
Premium
Weekend Updates
Sutro, Sarepta, Incyte, Signet, Wix: Trending by Analysts
3M ago
Sutro Biopharma price target lowered to 80c from $1 at BofA
PremiumThe FlySutro Biopharma price target lowered to 80c from $1 at BofA
4M ago
Sutro Biopharma Reports Q1 2025 Earnings and Restructuring
Premium
Company Announcements
Sutro Biopharma Reports Q1 2025 Earnings and Restructuring
5M ago
Sutro Biopharma: Hold Rating Amid Strategic Transition and Preclinical Focus
Premium
Ratings
Sutro Biopharma: Hold Rating Amid Strategic Transition and Preclinical Focus
5M ago
Sutro Biopharma presents expanded data from REFRalphaME-01 trial
PremiumThe FlySutro Biopharma presents expanded data from REFRalphaME-01 trial
6M ago
Sutro Biopharma Prioritizes ADC Programs Amid Financial Shift
Premium
Company Announcements
Sutro Biopharma Prioritizes ADC Programs Amid Financial Shift
7M ago
Oppenheimer cut Sutro to Perform, says ‘not too surprised’ with restructuring
Premium
The Fly
Oppenheimer cut Sutro to Perform, says ‘not too surprised’ with restructuring
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100